公司简介

Valerion Therapeutics develops therapies for orphan genetic muscle diseases utilizing a novel antibody-based targeting system.

主要成员

Dustin Armstrong

产品/服务

• 药物基因组

Valerion Therapeutics is utilizing a proprietary antibody-mediated delivery platform to target therapies to specific tissues via a well-known and broadly studied transport pathway.This platform is capable of enhanced intracellular delivery of a variety of active therapeutic payloads via a transport mechanism that is present in muscle and neurons and elevated in certain types of cancer. Pipeline candidates include therapeutic agents aimed at addressing a host of orphan genetic disorders with limited or no current therapies.

融资信息

关联公司